Document is current
Any future updates will be listed below
-
Authors
Sever, Sanja
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (RO1-DK087985)
- License Information
-
More Information
Article History
Received: 7 August 2020
Revised: 14 September 2020
Accepted: 5 October 2020
First Online: 13 November 2020
Compliance with ethical standards
:
: S. S. is the co-founder and shareholder of Trisaq, a biotechnology company that develops novel kidney-protective therapies.
